Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.
about
T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective VaccinesB Cells and Functional Antibody Responses to Combat InfluenzaThe unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccinesCross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primatesIncidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, FranceHumoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccinationSerial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.Disparities among 2009 pandemic influenza A (H1N1) hospital admissions: a mixed methods analysis--Illinois, April-December 2009.Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada.Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studiesCross-protection against European swine influenza viruses in the context of infection immunity against the 2009 pandemic H1N1 virus: studies in the pig model of influenza.Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strainsSeasonal Influenza Infections and Cardiovascular Disease Mortality.Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic.Study on age-dependent pre-existing 2009 pandemic influenza virus T and B cell responses from Chinese populationAge distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza.Serologic survey of the pandemic H1N1 2009 virus in Guangdong Province, China: a cross sectional study.Pandemic and seasonal human influenza virus infections in domestic cats: prevalence, association with respiratory disease, and seasonality patternsPandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everythingImmune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.Persistence of immunogenicity of a monovalent influenza virus A/H1N1 2009 vaccine in healthy volunteers.Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responsesInfluenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007-2010: the Ha Nam household cohort study ISearching for sharp drops in the incidence of pandemic A/H1N1 influenza by single year of age.Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans.H3N2v and other influenza epidemic risk based on age-specific estimates of sero-protection and contact network interactions.Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination.B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccinationInfluenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response.Re-engaging cross-reactive memory B cells: the influenza puzzle.The role of social contacts and original antigenic sin in shaping the age pattern of immunity to seasonal influenzaGLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Integration of immunity with physical and cognitive function in definitions of successful aging.HSC Aging and Senescent Immune Remodeling.
P2860
Q26768539-13876528-A8E2-4DBA-9D5A-4418F505A7C8Q26801639-86A3696B-19A4-439C-AE69-6A78F694AA1AQ27025076-6044F8FC-2BCF-49EE-B261-8C1BA7939CD2Q27348520-AA2587C0-623F-41FE-B4EE-346ACE858A35Q28730980-C1FE54BA-4818-47FE-8799-CCE91763AEA2Q28742312-ED21ADA1-59B7-4DA5-ABD1-DE5146283D9BQ30151372-39E88F62-E5A6-406D-B60B-432C2D7BA146Q30223476-A0CA919B-5F10-4841-8BE3-1C9553524CC5Q30361867-D839FA9F-B4EC-4E90-A51B-C511C26ECDD3Q30364076-8C0AD520-8066-4955-9062-A1E1A466F6D5Q30373077-098DBD9F-33D5-4543-8277-F986AA8C3E8AQ30376727-7FF4C078-23A6-49BC-B4DE-C664D27947CBQ30379517-CE11D6F4-96D6-42EA-BEB7-92F18F7946CBQ30382895-E09D3000-55B6-4B0F-A623-C2063D9F3D76Q30390770-9DBB858E-D0BA-4CC5-A8AF-1D282BC74C5AQ30394995-331C625B-3E5E-4620-AE65-D4BA7952AD60Q30398477-09A19CA6-321B-41F9-B731-5B0AB9DEBF60Q30404686-8B3AD984-09A1-4274-9B7C-179F5713316FQ30406154-AFA3BCBE-F0BF-4E5A-954C-EA382CBB2C6CQ30407590-B6654709-DF40-4FFF-A255-98186D74A5A3Q30407929-2D88C495-A3C6-47A6-9616-A577E9607003Q30410632-668D6A0D-2886-4F7F-9F70-C2D624BC095AQ30411189-661348EA-86EA-4449-B817-9652D9F088A8Q30411972-6E70C3D2-6881-4893-828F-199B140D5D7BQ30413489-2E839E8C-A83D-41D9-92BD-FBDC80C6DEE9Q30413677-C099310D-D7A2-4CCD-8F00-F0B2227422B0Q30414214-680683E1-A401-4401-8E07-8B4A38E6FFB9Q30420192-C1DACECF-22E1-46AA-B9EB-BE6594243EC9Q30421507-B8A4EA86-5D68-4308-A5AA-4D09CEE51062Q30421821-84350E46-632A-44E9-9671-ECED2B2B6B25Q30426038-E81E8913-CDA6-4656-B27F-46CDAC4F5558Q30426571-BDD7AD53-080C-4833-A11A-4C312FC11210Q30429248-AB0AD5A4-C56F-4C7D-918D-924BF030EB35Q31030019-16D5A410-A56F-4588-ADA5-CD1716B68A88Q33353517-9B3924C5-9E8C-44B4-8714-1785C0EFDFD1Q34468863-47E32AF5-8F1D-4DBF-88DF-23E84715BC73Q35669044-CA55685C-F999-4A83-90F2-9940D31F6F98Q35826733-AF793180-EA05-4068-8080-55877776ECCCQ35874100-E2533DD3-B134-4D9C-AEAD-9D36EFCAC739Q36455202-2E868BA2-00A8-44F5-9605-46745B1388F2
P2860
Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Immuno-epidemiologic correlate ...... e responses with advanced age.
@ast
Immuno-epidemiologic correlate ...... e responses with advanced age.
@en
type
label
Immuno-epidemiologic correlate ...... e responses with advanced age.
@ast
Immuno-epidemiologic correlate ...... e responses with advanced age.
@en
prefLabel
Immuno-epidemiologic correlate ...... e responses with advanced age.
@ast
Immuno-epidemiologic correlate ...... e responses with advanced age.
@en
P2093
P2860
P50
P356
P1476
Immuno-epidemiologic correlate ...... e responses with advanced age.
@en
P2093
Beth Gentleman
Dale Purych
Danuta M Skowronski
Janet E McElhaney
Jennifer Gardy
Martin Petric
Robert C Brunham
Suzana Sabaiduc
Tracy Chan
P2860
P304
P356
10.1093/INFDIS/JIQ039
P407
P577
2011-01-01T00:00:00Z